Igm Anti-mag Neuropathy

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-20
Clinical Trial Update: Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study
A clinical trial sponsored by Hospices Civils de Lyon evaluating a therapy for IgM anti-MAG peripheral neuropathy is currently recruiting.